Clinical Trials Directory

Trials / Completed

CompletedNCT01799733

Alternative Treatments for Premenstrual Dysphoric Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
University of California, San Diego · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this study is to examine the effects of co-administered wake therapy followed by light treatment on mood, and secondarily on circadian rhythms, to test the hypothesis that critically-timed chronotherapy improves mood by correcting phase disturbances in melatonin and sleep in women with Premenstrual Dysphoric Disorder.

Detailed description

The design is a randomized cross-over contrasting Late Wake Therapy plus morning bright light (LWT+Am BWL)vs. Early Wake Therapy plus evening bright light (EWT+PM BWL)administered in the luteal phase of two separate menstrual cycles, and preceded by 2 evaluation months. To lessen the patient's burden, the 1-night EWT or LWT and the following 7-day BWL interventions will be conducted at home, given at a fixed point in each menstrual cycle, from day 1 to 7 after the mid-cycle luteinizing hormone(LH) surge (ovulation). We anticipate that LWT+7 days of AM BWL (vs. EWT+PM BWL) will produce much greater mood benefits and larger physiological responses, than the one-time light pulses used in our earlier phase-shift studies.

Conditions

Interventions

TypeNameDescription
OTHERLWT+AM BWLOne night of late wake therapy (LWT)(sleep 21:00-01:00 h, followed by wakefulness) plus 7 days of morning bright white light (AM BWL)(light-emitting diode-LED administered for 60 minutes, starting within 30 minutes of habitual wake time)
OTHEREWT+PM BWLOne night of early wake therapy (EWT) (wakefulness until 03:00 h, then sleep 03:00-07:00 h) plus 7 nights of evening bright white light (PM BWL)(light-emitting diode-LED administered 90 minutes before habitual sleep onset, for 60 minutes)

Timeline

Start date
2013-06-18
Primary completion
2018-05-10
Completion
2018-07-03
First posted
2013-02-27
Last updated
2022-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01799733. Inclusion in this directory is not an endorsement.